前列腺癌放疗前后患者与医生症状报告一致性:HYPO-RT-PC随机研究
该研究为HYPO-RT-PC试验子研究,纳入1,180例接受常规或超低分次放疗的前列腺癌患者,比较患者报告与医生报告在基线和放疗后4年内的泌尿、肠道及性症状一致性。结果显示患者与医生评分相关性差(Spearman相关系数-0.091至0.750),医生持续低估泌尿和肠道症状、高估性活动,提示需系统整合患者报告结局。
要点
- 患者与医生对放疗相关症状的评分一致性总体较差,相关系数范围-0.091至0.750。
- 医生持续低估泌尿和肠道症状,高估性活动,勃起功能障碍结果不一致。
- 应系统整合患者报告结局以准确监测症状并实现以患者为中心的照护。
核心结论
- 患者与医生报告的放疗相关症状一致性总体较差。
- 医生评估存在系统偏差:低估泌尿和肠道症状,高估性活动。
- 需将患者报告结局系统整合入临床实践和研究。
研究设计与样本
- HYPO-RT-PC随机试验子研究,纳入1,180例前列腺癌患者。
- 患者随机接受常规放疗(2.0 Gy×39次)或超低分次放疗(6.1 Gy×7次),2005至2015年入组。
- 使用前列腺癌症状量表问卷和RTOG量表在基线、放疗结束时及放疗后1、2、4年评估症状。
主要发现
- 每次随访分析580-910对配对评估。
- 患者与医生评分的Spearman相关系数范围为-0.091至0.750。
- 医生持续低估泌尿和肠道症状,高估性活动,勃起功能障碍结果不一致。
关键数值与推荐
- 患者报告使用前列腺癌症状量表问卷,医生评估使用RTOG量表。
- 评估时间点为基线、放疗结束时及放疗后1、2、4年。
- Spearman相关系数范围-0.091至0.750。
临床怎么用
- 不应仅依赖医生评估来监测放疗相关症状。
- 应系统整合患者报告结局以准确监测症状。
- 临床实践和研究需纳入患者报告结局以实现以患者为中心的照护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Patient-reported outcome measures are recommended for monitoring treatment-related symptoms during radiotherapy (RT) for prostate cancer (PC). However, agreement between patient- and clinician-reported symptoms is often low. This study aimed to evaluate agreement between patient- and clinician-reported symptoms before and after radiotherapy for prostate cancer. MATERIALS AND METHODS: This sub-study of the HYPO-RT-PC trial included 1,180 men with PC randomized to conventional (2.0 Gy × 39 fx) or ultra-hypofractionated (6.1 Gy × 7 fx) RT between 2005 and 2015. Urinary, bowel, and sexual symptoms were assessed using the Prostate Cancer Symptom Scale questionnaire at baseline, at the end of RT, and at 1, 2, and 4 years post-treatment; clinicians evaluated symptoms at the same intervals using the Radiation Therapy Oncology Group scale. RESULTS: At each follow-up, 580-910 paired assessments were analyzed. Spearman's correlation between patient and clinician ratings ranged from -0.091 to 0.750. Clinicians consistently underrated urinary and bowel symptoms, overrated sexual activity, but results for erectile dysfunction were inconsistent. CONCLUSION: Agreement between patient- and clinician-reported RT-related symptoms was generally poor. These discrepancies highlight the limitations of relying solely on clinician assessment. They also underscore the need to integrate patient-reported outcome measures systematically into clinical practice and research to ensure accurate symptom monitoring and patient-centered care.
引用
- Rönningås U, Beckman L, Wennstig AK, et al. Patient-clinician symptom agreement before and after radiotherapy for prostate cancer: results from the randomized HYPO-RT-PC study. Radiother Oncol. 2026. PMID: 42732820. doi:10.1016/j.radonc.2026.111780
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。